» Articles » PMID: 20083352

Effect of Lingual Nerve Block on Burning Mouth Syndrome (stomatodynia): a Randomized Crossover Trial

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2010 Jan 20
PMID 20083352
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Burning mouth syndrome (stomatodynia) is associated with changes of a neuropathic nature the main location of which, peripheral or central, remains unknown. A randomised, double-blind crossover design was used to investigate the effects of lingual nerve block on spontaneous burning pain and a possible correlation with the effects of topical clonazepam, the patient's response to a psychological questionnaire, and the taste and heat thresholds. The spontaneous burning was measured with a visual analogue scale (VAS) just before and 15 min after injection. The decreases in VAS score after lidocaine or saline injection were not significantly different (2.7+/-3.9 and 2.0+/-2.6, respectively; n=20). However, two groups of patients could be identified: in a "peripheral group" (n=10) the VAS decrease due to lingual nerve injection was 4.3+/-3.1cm after lidocaine and 0.9+/-0.3 cm after saline (p=0.02). In a "central group" (n=7), there were an increase in pain intensity score (-0.8+/-2.6 cm) after lidocaine and a decrease (1.5+/-3.0 cm) after saline (p=0.15). An increase in the hospital anxiety and depression (HAD) score and a decreased taste sensitivity and heat pain threshold of painful oral area were seen in patients compared with age-and-sex-matched controls (p<0.05). Topical clonazepam treatment tended to be more effective (p=0.07) and HAD score lower (p<0.03) in the peripheral than in the central group. These results suggest that the neuropathic disorder associated with stomatodynia may be predominantly peripheral, central or mixed depending on the individual. Topical application of clonazepam and HAD may serve as indicators of which mechanism is dominating.

Citing Articles

Commentary: The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases.

Suga T, Toyofuku A Front Oral Health. 2025; 6:1556733.

PMID: 40008186 PMC: 11850541. DOI: 10.3389/froh.2025.1556733.


The Trigeminal Sensory System and Orofacial Pain.

Kim H, Chung K, Xing J, Kim H, Youn D Int J Mol Sci. 2024; 25(20).

PMID: 39457088 PMC: 11508441. DOI: 10.3390/ijms252011306.


Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.

Shin H, Bang J, Kim G, Kim M, Sun D, Kim S Sci Rep. 2023; 13(1):7257.

PMID: 37142613 PMC: 10160112. DOI: 10.1038/s41598-023-33983-6.


Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.

Zborowski J, Konopka T Int J Environ Res Public Health. 2022; 19(15).

PMID: 35897370 PMC: 9330819. DOI: 10.3390/ijerph19158999.


A Narrative Review of Therapeutic Peripheral Nerve Blocks for Chronic Orofacial Pain Conditions.

Renton T, Beke A J Oral Facial Pain Headache. 2022; 36(1):49-58.

PMID: 35298575 PMC: 10586588. DOI: 10.11607/ofph.3017.